Back to Search
Start Over
Genetically Proxied IL-6 Receptor Inhibition and Coronary Artery Disease Risk in a Japanese Population.
- Source :
-
Clinical therapeutics [Clin Ther] 2024 Aug; Vol. 46 (8), pp. 657-658. Date of Electronic Publication: 2024 May 31. - Publication Year :
- 2024
-
Abstract
- Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dipender Gill reports a relationship with Novo Nordisk that includes: employment. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
- Subjects :
- Aged
Female
Humans
Male
Middle Aged
Antibodies, Monoclonal, Humanized therapeutic use
Antibodies, Monoclonal, Humanized adverse effects
Asian People genetics
East Asian People
Japan epidemiology
Polymorphism, Single Nucleotide
Risk Factors
Coronary Artery Disease genetics
Coronary Artery Disease epidemiology
Receptors, Interleukin-6 genetics
Receptors, Interleukin-6 antagonists & inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 1879-114X
- Volume :
- 46
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Clinical therapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 38821768
- Full Text :
- https://doi.org/10.1016/j.clinthera.2024.04.015